| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/28/2008 | WO2008022772A1 Use of light sensitive genes |
| 02/28/2008 | WO2008022468A1 Compositions and methods for treating myelosuppression |
| 02/28/2008 | WO2007069090A3 Cell penetrating peptides for intracellular delivery of molecules |
| 02/28/2008 | WO2000040692A3 Methods and compositions for delivering nucleic acids |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051355 System for obfuscating identity |
| 02/28/2008 | US20080051354 Human schwannoma cell line |
| 02/28/2008 | US20080051347 Tumour-associated peptides binding to mhc-molecules |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051337 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 02/28/2008 | US20080051335 Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers |
| 02/28/2008 | US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050770 Method for the production and purification of adenoviral vectors |
| 02/28/2008 | US20080050719 Gene expression profiles in liver disease |
| 02/28/2008 | US20080050416 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050378 A ribonucleotide sequence corresponding to a gene KIF11 target sequence, where the antisense strand comprises a ribonucleotide sequence complementary to the sense strand; sense/anntisense strands hybridize to form double-stranded molecule which inhibits cell expression of KIf11 (SEQ ID NO: 34) |
| 02/28/2008 | US20080050372 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050349 Cell based therapy for the pulmonary system |
| 02/28/2008 | US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
| 02/28/2008 | US20080050343 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same |
| 02/28/2008 | US20080050342 Genetic inhibition by double-stranded RNA |
| 02/28/2008 | US20080050341 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 02/28/2008 | CA2661669A1 A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangniocarcinoma |
| 02/28/2008 | CA2661292A1 Compositions and methods for treating myelosuppression |
| 02/28/2008 | CA2660696A1 Use of light sensitive genes |
| 02/28/2008 | CA2658000A1 Use of cd83 in combination therapies |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892298A1 Streptococcal C5a peptidase vaccine |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1891976A1 Use of light sensitive genes |
| 02/27/2008 | EP1891965A1 Hip-Kinase for fertility controll |
| 02/27/2008 | EP1891943A2 Nanoparticles comprising chitosan and cyclodextrin |
| 02/27/2008 | EP1891236A2 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
| 02/27/2008 | EP1891115A2 Anti her2/neu antibody |
| 02/27/2008 | EP1890708A1 Glucose inducible insulin expression and methods of treating diabetes |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1507560B1 Immune stimulating and controlling composition comprising bacterial chromosomal dna fragments and non-toxic lipopolysaccharides |
| 02/27/2008 | EP1471143B1 Method and kit of judging the onset of rheumatoid arthritis |
| 02/27/2008 | EP1438393B1 Differentiation of whole bone marrow |
| 02/27/2008 | EP1329504B1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1141278B1 Therapeutic pde4d phosphodiesterase inhibitors |
| 02/27/2008 | EP1137758B1 Method and composition for preserving adenoviruses |
| 02/27/2008 | EP0981549B9 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN101133156A Chinese hamster apoptosis-related genes |
| 02/27/2008 | CN101130779A Method for regulating and controlling adenovirus protein by double promoter and use thereof |
| 02/27/2008 | CN101130774A Nucleotide molecule SR5B and its application in preparation of antidiabetic medicine |
| 02/27/2008 | CN101130773A Nucleotide molecule SR5B2 and its application in preparation of antidiabetic medicine |
| 02/27/2008 | CN101130772A Nucleotide molecule SR4B2 and its application in preparation of antidiabetic medicine |
| 02/27/2008 | CN101130771A Nucleotide molecule SR3B2 and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130770A Nucleotide molecule SR2B and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130769A Nucleotide molecule SR4B and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130768A Nucleotide molecule SR1B and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130571A Human ring protein, encoding gene and application of the same |
| 02/27/2008 | CN101130565A Nucleotide molecule SR3B and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130564A Nucleotide molecule SR2B2 and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130563A Nucleotide molecule SR1B2 and application of the same in producing antidiabetic medicament |
| 02/27/2008 | CN101130092A Application of recombinant adenovirus in producing antineoplastic medicine |
| 02/27/2008 | CN101130091A DNA vaccine for treating atrophic arthritis and uses of the same |
| 02/27/2008 | CN101130090A Application of BRSK2 in producing antidiabetic medicine |
| 02/27/2008 | CN101130086A Method for preparing drug administration carrier of gene with polyethylene imine beautify chitosan |
| 02/27/2008 | CN100371444C VEGF expression-inhibiting siRNA and application thereof |
| 02/27/2008 | CN100371021C Anti-lymphadenoma gene family specificity nucleic acid vaccine combination |
| 02/26/2008 | US7337011 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 02/26/2008 | US7335765 Nucleoside and oligonucleotide analogues |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335754 Ehrlichia canis genes and vaccines |
| 02/26/2008 | US7335750 Hybrid compositions for intracellular targeting |
| 02/26/2008 | US7335647 Drugs for liver diseases |
| 02/26/2008 | US7335646 Compositions and methods for regulated protein expression in gut |
| 02/26/2008 | US7335641 Method for stimulating hair follicle cell proliferation |
| 02/26/2008 | US7335505 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/26/2008 | US7335499 tRNA synthetase |
| 02/26/2008 | US7335482 Method using neutral amino acid transporter expressing cell |
| 02/26/2008 | US7335475 nucleotide sequences coding tumor suppressor (PR/SET) polypeptides for diagnosis, prognosis and treatment of cell proliferative disorders; anticarcinogenic agents; tumor suppressor genes |
| 02/26/2008 | US7335468 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 02/26/2008 | US7335364 Modified Vaccinia Ankara virus variant |
| 02/26/2008 | US7335357 Antagonists of neuropilin receptor function and use thereof |
| 02/26/2008 | US7335353 Porcine cells comprising an adenovirus E3 gene region |
| 02/26/2008 | US7335351 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 02/26/2008 | CA2353788C Human cervical cancer 1 protooncogene and protein encoded therein |
| 02/21/2008 | WO2008022278A2 Atypical pkc mediates wnt signaling in growth cone guidance |
| 02/21/2008 | WO2008022253A2 An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions |
| 02/21/2008 | WO2008022153A2 Inhibitors of pde4 and methods of use |
| 02/21/2008 | WO2008022113A2 Methods for treating rheumatoid arthritis |
| 02/21/2008 | WO2008021456A2 N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/21/2008 | WO2008021193A2 Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells |
| 02/21/2008 | WO2008021149A2 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 02/21/2008 | WO2008021136A2 Methods and sequences to suppress primate huntington gene expression in vivo |